Effects of Whole-Body Vibration on Heart Rate Variability During Post-Exercise Recovery (WBV-HRV)
Effects of Whole-Body Vibration Versus Passive Recovery on Frequency-Domain Heart Rate Variability Following High-Intensity Exercise: A Randomized Crossover Trial
This study aims to investigate the acute effects of whole-body vibration (WBV) and passive recovery on heart rate variability (HRV) following high-intensity intermittent exercise in male soccer players.
Ten male soccer players will participate in a randomized, two-period crossover study. Each participant will complete two experimental sessions separated by a seven-day washout period. During each session, participants will perform the Yo-Yo Intermittent Recovery Test Level 1 until exhaustion, followed by either 15 minutes of seated whole-body vibration or 15 minutes of seated passive recovery.
During the WBV condition, participants will remain seated with their knees flexed at approximately 90 degrees and their bare feet positioned on a vibration platform operating at 35 Hz with a peak-to-peak amplitude of 2 mm. During passive recovery, participants will remain seated without vibration.
Heart rate variability will be continuously recorded throughout the exercise test and the entire 15-minute recovery period using a chest-strap heart rate sensor. Frequency-domain HRV parameters, including very-low-frequency (VLF), low-frequency (LF), and high-frequency (HF) power, will be analyzed.
The study will compare the autonomic responses associated with the two recovery methods to determine whether seated whole-body vibration produces different short-term HRV responses compared with passive recovery.
調査の概要
詳細な説明
This study is designed as a randomized, two-period crossover trial to examine the acute effects of whole-body vibration (WBV) and passive recovery on frequency-domain heart rate variability (HRV) following exhaustive intermittent exercise.
Ten male soccer players will participate in the study. Participants will be randomly assigned to one of two intervention sequences: WBV followed by passive recovery (AB) or passive recovery followed by WBV (BA). A seven-day washout period will separate the experimental sessions to minimize potential carryover effects.
At each experimental session, participants will complete the Yo-Yo Intermittent Recovery Test Level 1 until voluntary exhaustion. Following exercise, participants will undergo a 15-minute recovery intervention according to their assigned sequence.
During the WBV intervention, participants will sit on a chair with their knees flexed at approximately 90 degrees and their bare feet placed on a vertical vibration platform operating at 35 Hz with a peak-to-peak displacement of 2 mm. During the passive recovery intervention, participants will remain seated in a comparable position with their feet resting on the floor and without vibration exposure.
Heart rate variability will be recorded continuously throughout the exercise test and the complete 15-minute recovery period using a Polar H10 chest-strap sensor. HRV data will be processed using Kubios HRV software to obtain frequency-domain parameters, including VLF, LF, and HF power.
The primary objective is to compare frequency-domain HRV responses between WBV and passive recovery conditions. Statistical analyses will account for the paired crossover design and evaluate differences between recovery conditions.
The findings are expected to contribute to the understanding of acute autonomic responses to whole-body vibration as a post-exercise recovery intervention in soccer players.
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前：Hamza Budak, PhD
- 電話番号：+905065181266
- メール：hamzabudak@aksaray.edu.tr
研究場所
-
-
Aksaray
-
Aksaray、Aksaray、トルコ（Türkiye）、68100
- Aksaray University, Faculty of Sport Sciences
-
コンタクト：
- Hamza Budak, PhD
- 電話番号：+905065181266
- メール：hamzabudak@aksaray.edu.tr
-
コンタクト：
-
主任研究者：
- Hamza Budak, Phd
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Male soccer players within the predefined eligible age range.
- Regular participation in soccer training.
- Ability to complete the Yo-Yo Intermittent Recovery Test Level 1.
- Willingness to participate in both experimental sessions.
- Provision of written informed consent.
Exclusion Criteria:
- Known cardiovascular, neurological, or musculoskeletal disorders that could affect exercise performance or heart rate variability.
- Current injury or illness preventing maximal exercise.
- Use of medications known to influence autonomic nervous system activity or heart rate variability.
- Any contraindication to whole-body vibration exposure.
研究計画
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：処理
- 割り当て：ランダム化
- 介入モデル：クロスオーバー割り当て
- マスキング：なし（オープンラベル）
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的：Sequence AB (WBV → Passive Recovery)
Participants assigned to Sequence AB will undergo whole-body vibration (WBV) recovery during the first experimental period, followed by passive recovery during the second period. A seven-day washout period will separate the two sessions. Both recovery interventions will last 15 minutes and will be performed in a seated position following the Yo-Yo Intermittent Recovery Test Level 1. During WBV recovery, participants will remain seated with their feet placed on the vibration platform, operating at 35 Hz and 2 mm peak-to-peak amplitude. |
Participants assigned to the whole-body vibration (WBV) intervention will undergo a 15-minute recovery session immediately following the Yo-Yo Intermittent Recovery Test Level 1. During the intervention, participants will remain seated on a chair with their knees flexed at approximately 90 degrees and their bare feet placed on a vertical vibration platform. The platform will operate at a frequency of 35 Hz and a peak-to-peak amplitude of 2 mm. Heart rate variability will be continuously recorded throughout the 15-minute recovery period to evaluate autonomic nervous system responses. Participants assigned to the passive recovery intervention will undergo a 15-minute seated recovery session immediately following the Yo-Yo Intermittent Recovery Test Level 1. During this period, participants will remain seated on a chair with their feet resting on the floor, without receiving whole-body vibration or any other active recovery intervention. Heart rate variability will be continuously recorded throughout the 15-minute recovery period to evaluate autonomic nervous system responses. |
|
実験的：Sequence BA (Passive Recovery → WBV)
Participants assigned to Sequence BA will undergo passive recovery during the first experimental period, followed by whole-body vibration (WBV) recovery during the second period. A seven-day washout period will separate the two sessions. Both recovery interventions will last 15 minutes and will be performed in a seated position following the Yo-Yo Intermittent Recovery Test Level 1. During passive recovery, participants will remain seated with their feet resting on the floor. During WBV recovery, participants will remain seated with their feet placed on the vibration platform, operating at 35 Hz and 2 mm peak-to-peak amplitude. |
Participants assigned to the whole-body vibration (WBV) intervention will undergo a 15-minute recovery session immediately following the Yo-Yo Intermittent Recovery Test Level 1. During the intervention, participants will remain seated on a chair with their knees flexed at approximately 90 degrees and their bare feet placed on a vertical vibration platform. The platform will operate at a frequency of 35 Hz and a peak-to-peak amplitude of 2 mm. Heart rate variability will be continuously recorded throughout the 15-minute recovery period to evaluate autonomic nervous system responses. Participants assigned to the passive recovery intervention will undergo a 15-minute seated recovery session immediately following the Yo-Yo Intermittent Recovery Test Level 1. During this period, participants will remain seated on a chair with their feet resting on the floor, without receiving whole-body vibration or any other active recovery intervention. Heart rate variability will be continuously recorded throughout the 15-minute recovery period to evaluate autonomic nervous system responses. |
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Very Low Frequency (VLF) Power
時間枠：During the exercise test and the subsequent 15-minute recovery period in each experimental session.
|
Very low frequency (VLF) power is a frequency-domain parameter of heart rate variability (HRV), expressed in ms². HRV will be continuously recorded using a Polar H10 chest strap during the entire exercise test and the 15-minute recovery period. VLF power will be analyzed using Kubios HRV software to assess autonomic responses under whole-body vibration and passive recovery conditions. |
During the exercise test and the subsequent 15-minute recovery period in each experimental session.
|
|
Low Frequency (LF) Power
時間枠：During the exercise test and the subsequent 15-minute recovery period in each experimental session.
|
Low frequency (LF) power is a frequency-domain parameter of heart rate variability (HRV), expressed in ms². HRV will be continuously recorded using a Polar H10 chest strap during the entire exercise test and the 15-minute recovery period. LF power will be analyzed using Kubios HRV software to evaluate autonomic responses under whole-body vibration and passive recovery conditions. |
During the exercise test and the subsequent 15-minute recovery period in each experimental session.
|
|
High Frequency (HF) Power
時間枠：During the exercise test and the subsequent 15-minute recovery period in each experimental session.
|
High frequency (HF) power is a frequency-domain parameter of heart rate variability (HRV), expressed in ms², and is commonly used as an indicator of cardiac parasympathetic modulation. HRV will be continuously recorded using a Polar H10 chest strap during the entire exercise test and the 15-minute recovery period. HF power will be analyzed using Kubios HRV software to compare responses between whole-body vibration and passive recovery conditions. |
During the exercise test and the subsequent 15-minute recovery period in each experimental session.
|
協力者と研究者
スポンサー
研究記録日
主要日程の研究
研究開始 (推定)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
キーワード
その他の研究ID番号
- ASU-HRV-WBV-2026-01
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
Individual participant data will not be made publicly available due to participant confidentiality and data protection considerations. Only aggregated and anonymized study results will be reported in scientific publications.
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。